Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Marketing In Brief

Executive Summary

Dermify: "The first and only 100% natural, FDA-compliant, over-the-counter acne treatment," according to the company, Dermify All-In-One Acne Solution is formulated with FDA-approved sulfur colloid (5%) as well as "antioxidant-rich fruits, raw nectars, nut and seed extracts" to gently exfoliate skin while mineral-rich clays lift out impurities and minimize pores and micronutrient-rich herbs improve skin tone and texture and prevent future breakouts, Dermify says. Company positions its product as a safe alternative to prescription drugs such as Proactiv and Accutane, formulated without the "harsh chemicals" like benzoyl peroxide and salicylic acid in competing OTC products. In a clinical study, 26.2% of subjects ages 13 to 36 reported seeing initial improvement in 1 to 3 days, and 29.4% in 7 to 9 days, while 59.5% and 18.3% of participants agreed and strongly agreed, respectively, that they would switch from "chemical-based acne treatments" to Dermify. The "one-step, one-tube, zero-hassle solution" can be purchased at Dermify.com for $39.95
Advertisement

Related Content

Keep An Eye On Neighboring Industries For Next Big Cosmetic Ingredient
Keep An Eye On Neighboring Industries For Next Big Cosmetic Ingredient
Dr. Jacknin Profiles "Cutting-Edge" Natural Cosmeceutical Ingredients
Dr. Jacknin Profiles "Cutting-Edge" Natural Cosmeceutical Ingredients
Advertisement
UsernamePublicRestriction

Register

RS016611

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel